Free Trial

Dynamic Technology Lab Private Ltd Acquires Shares of 13,811 Doximity, Inc. $DOCS

Doximity logo with Medical background

Key Points

  • Dynamic Technology Lab Private Ltd made a new investment of approximately $801,000 in Doximity, acquiring 13,811 shares during the first quarter.
  • Analyst ratings for Doximity include a mix of two Strong Buy, ten Buy, and eleven Hold ratings, with an average target price set at $66.21.
  • Insider trading activity showed a significant decrease in ownership for two directors, with 32,000 shares sold in the past ninety days, valued at approximately $1.93 million.
  • Interested in Doximity? Here are five stocks we like better.

Dynamic Technology Lab Private Ltd acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 13,811 shares of the company's stock, valued at approximately $801,000.

Several other institutional investors and hedge funds also recently bought and sold shares of DOCS. Cetera Investment Advisers boosted its holdings in Doximity by 14.6% in the 4th quarter. Cetera Investment Advisers now owns 8,097 shares of the company's stock worth $432,000 after buying an additional 1,034 shares during the period. Cubist Systematic Strategies LLC bought a new position in Doximity in the 4th quarter worth approximately $2,544,000. Graham Capital Management L.P. bought a new position in Doximity in the 4th quarter worth approximately $1,797,000. Occudo Quantitative Strategies LP bought a new position in Doximity in the 4th quarter worth approximately $1,112,000. Finally, Nuveen Asset Management LLC boosted its holdings in Doximity by 48.0% in the 4th quarter. Nuveen Asset Management LLC now owns 464,658 shares of the company's stock valued at $24,808,000 after purchasing an additional 150,734 shares during the period. 87.19% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

DOCS has been the subject of several analyst reports. KeyCorp raised their price target on shares of Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Wells Fargo & Company raised their price target on shares of Doximity from $55.00 to $62.00 and gave the company an "equal weight" rating in a report on Monday, August 4th. BTIG Research raised shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target for the company in a report on Monday, June 2nd. Bank of America raised their price target on shares of Doximity from $55.00 to $62.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. Finally, William Blair reissued an "outperform" rating on shares of Doximity in a report on Friday, May 16th. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $67.00.

Read Our Latest Report on DOCS

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 10,000 shares of Doximity stock in a transaction on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total value of $600,000.00. Following the transaction, the director owned 6,360 shares in the company, valued at $381,600. This trade represents a 61.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total transaction of $114,180.00. Following the completion of the transaction, the director owned 16,618 shares in the company, valued at approximately $948,721.62. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,000 shares of company stock worth $1,929,380 in the last 90 days. 31.30% of the stock is owned by company insiders.

Doximity Trading Up 1.1%

Shares of Doximity stock traded up $0.79 on Friday, hitting $71.05. 1,374,597 shares of the company traded hands, compared to its average volume of 2,224,099. The firm's 50-day simple moving average is $63.42 and its 200 day simple moving average is $59.93. The company has a market cap of $13.31 billion, a P/E ratio of 71.05, a P/E/G ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a 12-month low of $38.30 and a 12-month high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The business's quarterly revenue was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current year.

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.